Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy

Detalhes bibliográficos
Autor(a) principal: Lima, Patricia Azevedo de
Data de Publicação: 2014
Outros Autores: Sampaio, Leticia Pereira de Brito, Damasceno, Nágila Raquel Teixeira
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/96929
Resumo: A ketogenic diet is an important therapy used in the control of drug-refractory seizures. Many studies have shown that children and adolescents following ketogenic diets exhibit an over 50% reduction in seizure frequency, which is considered to be clinically relevant. These benefits are based on a diet containing high fat (approximately 90% fat) for 24 months. This dietary model was proposed in the 1920s and has produced variable clinical responses. Previous studies have shown that the mechanisms underlying seizure control involve ketone bodies, which are produced by fatty acid oxidation. Although the pathways involved in the ketogenic diet are not entirely clear, the main effects of the production of ketone bodies appear to be neurotransmitter modulation and antioxidant effects on the brain. This review highlights the impacts of the ketogenic diet on the modulation of neurotransmitters, levels of biogenic monoamines and protective antioxidant mechanisms of neurons. In addition, future perspectives are proposed.
id USP-19_f378d9e92efbdfb4a3afd35bbfb2f7c7
oai_identifier_str oai:revistas.usp.br:article/96929
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy A ketogenic diet is an important therapy used in the control of drug-refractory seizures. Many studies have shown that children and adolescents following ketogenic diets exhibit an over 50% reduction in seizure frequency, which is considered to be clinically relevant. These benefits are based on a diet containing high fat (approximately 90% fat) for 24 months. This dietary model was proposed in the 1920s and has produced variable clinical responses. Previous studies have shown that the mechanisms underlying seizure control involve ketone bodies, which are produced by fatty acid oxidation. Although the pathways involved in the ketogenic diet are not entirely clear, the main effects of the production of ketone bodies appear to be neurotransmitter modulation and antioxidant effects on the brain. This review highlights the impacts of the ketogenic diet on the modulation of neurotransmitters, levels of biogenic monoamines and protective antioxidant mechanisms of neurons. In addition, future perspectives are proposed. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2014-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/9692910.6061/clinics/2014(10)09Clinics; Vol. 69 No. 10 (2014); 699-705Clinics; v. 69 n. 10 (2014); 699-705Clinics; Vol. 69 Núm. 10 (2014); 699-7051980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/96929/96009Copyright (c) 2015 Clinicsinfo:eu-repo/semantics/openAccessLima, Patricia Azevedo de Sampaio, Leticia Pereira de Brito Damasceno, Nágila Raquel Teixeira 2015-03-27T17:35:39Zoai:revistas.usp.br:article/96929Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2015-03-27T17:35:39Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
title Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
spellingShingle Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
Lima, Patricia Azevedo de
title_short Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
title_full Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
title_fullStr Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
title_full_unstemmed Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
title_sort Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy
author Lima, Patricia Azevedo de
author_facet Lima, Patricia Azevedo de
Sampaio, Leticia Pereira de Brito
Damasceno, Nágila Raquel Teixeira
author_role author
author2 Sampaio, Leticia Pereira de Brito
Damasceno, Nágila Raquel Teixeira
author2_role author
author
dc.contributor.author.fl_str_mv Lima, Patricia Azevedo de
Sampaio, Leticia Pereira de Brito
Damasceno, Nágila Raquel Teixeira
description A ketogenic diet is an important therapy used in the control of drug-refractory seizures. Many studies have shown that children and adolescents following ketogenic diets exhibit an over 50% reduction in seizure frequency, which is considered to be clinically relevant. These benefits are based on a diet containing high fat (approximately 90% fat) for 24 months. This dietary model was proposed in the 1920s and has produced variable clinical responses. Previous studies have shown that the mechanisms underlying seizure control involve ketone bodies, which are produced by fatty acid oxidation. Although the pathways involved in the ketogenic diet are not entirely clear, the main effects of the production of ketone bodies appear to be neurotransmitter modulation and antioxidant effects on the brain. This review highlights the impacts of the ketogenic diet on the modulation of neurotransmitters, levels of biogenic monoamines and protective antioxidant mechanisms of neurons. In addition, future perspectives are proposed.
publishDate 2014
dc.date.none.fl_str_mv 2014-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/96929
10.6061/clinics/2014(10)09
url https://www.revistas.usp.br/clinics/article/view/96929
identifier_str_mv 10.6061/clinics/2014(10)09
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/96929/96009
dc.rights.driver.fl_str_mv Copyright (c) 2015 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2015 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 69 No. 10 (2014); 699-705
Clinics; v. 69 n. 10 (2014); 699-705
Clinics; Vol. 69 Núm. 10 (2014); 699-705
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222761673555968